- Report
- October 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- March 2023
- 9 Pages
Global
From €2995EUR$3,150USD£2,516GBP
- Report
- August 2021
- 11 Pages
Global
From €2995EUR$3,150USD£2,516GBP
Oncology Ablation is a medical procedure used to treat cancer by destroying or removing cancerous tissue. It is used to treat tumors that are too small or too deep to be treated with surgery, or when surgery is not an option. Ablation can be used to treat a variety of cancers, including liver, kidney, lung, and prostate cancer. It is also used to treat some types of brain tumors. Ablation is typically performed using either radiofrequency ablation (RFA) or microwave ablation (MWA). RFA uses high-frequency radio waves to heat and destroy cancer cells, while MWA uses microwaves to heat and destroy cancer cells.
The Oncology Ablation market is a rapidly growing segment of the Oncology Drugs market. It is driven by the increasing prevalence of cancer, the development of new technologies, and the increasing demand for minimally invasive treatments. Companies in the Oncology Ablation market include AngioDynamics, Boston Scientific, Medtronic, Stryker, and Smith & Nephew. Show Less Read more